Bone regeneration and repair

Current Stem Cell Research and Therapy

Volumn 5, Issue 2, 2010, Pages 122-128

  Panetta, Nicholas J ^a   Gupta, Deepak M ^a   Longaker, Michael T ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Adipose derived stromal cells; Craniosynostosis; Distraction osteogenesis; Regenerative medicine; Skeletal regeneration; Tissue engineering

Indexed keywords

BETA1 INTEGRIN; BIOMATERIAL; BONE MORPHOGENETIC PROTEIN; ENDOGLIN; FIBROBLAST GROWTH FACTOR 1; THY 1 ANTIGEN; TRANSFORMING GROWTH FACTOR BETA;

ADIPOSE DERIVED STEM CELL; ARTICLE; BIOENGINEERING; BONE DEVELOPMENT; BONE REGENERATION; BONE REMODELING; CELL DIFFERENTIATION; CRANIOFACIAL SYNOSTOSIS; DISTRACTION OSTEOGENESIS; HEMATOPOIETIC STEM CELL; IN VITRO STUDY; MESENCHYMAL STEM CELL; MOLECULAR BIOLOGY; MULTIPOTENT STEM CELL; PRIORITY JOURNAL; REGENERATIVE MEDICINE; TISSUE ENGINEERING; ADIPOSE TISSUE; ANIMAL; ANIMAL MODEL; HUMAN; INDUCED PLURIPOTENT STEM CELL; METABOLISM; PATHOLOGY; STEM CELL NICHE; TISSUE REGENERATION; TISSUE SCAFFOLD; UTILIZATION;

ADIPOSE TISSUE; ANIMALS; BIOCOMPATIBLE MATERIALS; BONE REGENERATION; GUIDED TISSUE REGENERATION; HUMANS; INDUCED PLURIPOTENT STEM CELLS; MODELS, ANIMAL; OSTEOGENESIS; STEM CELL NICHE; TISSUE ENGINEERING; TISSUE SCAFFOLDS;

EID: 77954055359     PISSN: 1574888X     EISSN: None     Source Type: Journal    
DOI: 10.2174/157488810791268618     Document Type: Article

References (103)

1. HCUP. Healthcare Cost and Utilization Project. 2007 [cited; http://www.ahrq.gov/data/hcup/]. Available from: http://hcup.ahrq.-gov/HCUPnet.asp
2. Perry CR. Bone repair techniques, bone graft, and bone graft substitutes. Clin Orthop Relat Res 1999; (360): 71-86.
3. Fernyhough JC, Schimandle JJ, Weigel MC, Edwards CC, Levine AM. Chronic donor site pain complicating bone graft harvesting from the posterior iliac crest for spinal fusion. Spine 1992; 17(12): 1474-80.
4. Heary RF, Schlenk RP, Sacchieri TA, Barone D, Brotea C. Persistent iliac crest donor site pain: independent outcome assessment. Neurosurgery 2002; 50(3): 510-6; discussion 6-7.
5. Laurencin C, Khan Y, El-Amin SF. Bone graft substitutes. Expert Rev Med Devices 2006; 3(1): 49-57.
6. Younger EM, Chapman MW. Morbidity at bone graft donor sites. J Orthop Trauma 1989; 3(3): 192-5.
7. rd ed. Elsevier Academic Press 2007; pp. 935-44.
8. Codivilla A. On the means of lengthening in the lower limbs, the muscles and tissues which are shortened through deformity. Am J Orthop Surg 1905; 2: 353-69.
9. Ilizarov GA. The tension-stress effect on the genesis and growth of tissues: Part II. The influence of the rate and frequency of distraction. Clin Orthop 1989; (239): 263-85.
10. Ilizarov GA. The tension-stress effect on the genesis and growth of tissues. Part I. The influence of stability of fixation and soft-tissue preservation. Clin Orthop 1989; (238): 249-81.
11. Ilizarov GA, Deviatov AA. Surgical elongation of the leg. Ortop Travmatol Protez 1971; 32(8): 20-5.
12. Ilizarov GA, Lediaev VI, Shitin VP. The course of compact bone reparative regeneration in distraction osteosynthesis under different conditions of bone fragment fixation (experimental study). Eksp Khir Anesteziol 1969; 14(6): 3-12.
13. McCarthy JG, Schreiber J, Karp N, Thorne CH, Grayson BH. Lengthening the human mandible by gradual distraction. Plast Reconstr Surg 1992; 89(1): 1-8.
14. Imola MJ, Hamlar DD, Thatcher G, Chowdhury K. The versatility of distraction osteogenesis in craniofacial surgery. Arch Facial Plast Surg 2002; 4(1): 8-19.
15. McCarthy J. The role of distraction osteogenesis in the reconstruction of the mandible in unilateral craniofacial microsomia. Clin Plast Surg 1994; 21: 625-31.
16. McCarthy JG, Katzen JT, Hopper R, Grayson BH. The first decade of mandibular distraction: lessons we have learned. Plast Reconstr Surg 2002; 110(7): 1704-13.
17. McCarthy JG, Stelnicki EJ, Grayson BH. Distraction osteogenesis of the mandible: a ten-year experience. Semin Orthod 1999; 5(1): 3-8.
18. McCarthy JG, Stelnicki EJ, Mehrara BJ, Longaker MT. Distraction osteogenesis of the craniofacial skeleton. Plast Reconstr Surg 2001; 107(7): 1812-27.
19. Gosain AK. Distraction osteogenesis of the craniofacial skeleton. Plast Reconstr Surg 2001; 107(1): 278-80.
20. Cohen SR, Burstein FD, Williams JK. The role of distraction osteogenesis in the management of craniofacial disorders. Ann Acad Med Singapore 1999; 28(5): 728-38.
21. Rowe NM, Mehrara BJ, Dudziak ME, et al. Rat mandibular distraction osteogenesis: Part I. Histologic and radiographic analysis. Plast Reconstr Surg 1998; 102(6): 2022-32.
22. Buchman SR, Ignelzi MA Jr, Radu C, et al. Unique rodent model of distraction osteogenesis of the mandible. Ann Plast Surg 2002; 49(5): 511-9.
23. Bouletreau PJ, Warren SM, Paccione MF, Spector JA, McCarthy JG, Longaker MT. Transport distraction osteogenesis: A new method to heal adult calvarial defects. Plast Reconstr Surg 2002; 109(3): 1074-84.
24. Yeung HY, Lee SK, Fung KP, Leung KS. Expression of basic fibroblast growth factor during distraction osteogenesis. Clin Orthop 2001; (385): 219-29.
25. Li G, Bouxsein ML, Luppen C, et al. Bone consolidation is enhanced by rhBMP-2 in a rabbit model of distraction osteogenesis. J Orthop Res 2002; 20(4): 779-88.
26. Linkhart TA, Mohan S, Baylink DJ. Growth factors for bone growth and repair: IGF, TGF beta and BMP. Bone 1996; 19(1 Suppl): 1S-12S.
27. Prisell PT, Edwall D, Lindbald JB, Levinovitz A, Norstedt G. Expression of insulin-like growth factors during bone induction in rat. Calcific Tiss Int 1993; 53: 201.
28. Ashinoff RL, Cetrulo CL Jr, Galiano RD, et al. Bone morphogenic protein-2 gene therapy for mandibular distraction osteogenesis. Ann Plast Surg 2004; 52(6): 585-90; discussion 91.
29. Campisi P, Hamdy RC, Lauzier D, Amako M, Rauch F, Lessard ML. Expression of bone morphogenetic proteins during mandibular distraction osteogenesis. Plast Reconstr Surg 2003; 111(1): 201-8; discussion 9-10.
30. Bouletreau PJ, Warren SM, Longaker MT. The molecular biology of distraction osteogenesis. J Craniomaxillofac Surg 2002; 30(1): 1-11.
31. Byun JH, Park BW, Kim JR, Lee JH. Expression of vascular endothelial growth factor and its receptors after mandibular distraction osteogenesis. Int J Oral Maxillofac Surg 2007; 36(4): 338-44.
32. Rhee ST, El-Bassiony L, Buchman SR. Extracellular signal-related kinase and bone morphogenetic protein expression during distraction osteogenesis of the mandible: in vivo evidence of a mechanotransduction mechanism for differentiation and osteogenesis by mesenchymal precursor cells. Plast Reconstr Surg 2006; 117(7): 2243-9.
33. Tong L, Buchman SR, Ignelzi MA Jr, Rhee S, Goldstein SA. Focal Adhesion Kinase Expression during Mandibular Distraction Osteogenesis: Evidence for Mechanotransduction. Plast Reconstr Surg 2003; 111(1): 211-22.
34. Pacicca DM, Patel N, Lee C, Salisbury K, et al. Expression of angiogenic factors during distraction osteogenesis. Bone 2003; 33(6): 889-98.
35. Hu J, Zou S, Li J, Chen Y, Wang D, Gao Z. Temporospatial expression of vascular endothelial growth factor and basic fibroblast growth factor during mandibular distraction osteogenesis. J Craniomaxillofac Surg 2003; 31(4): 238-43.
36. Eckardt H, Bundgaard KG, Christensen KS, Lind M, Hansen ES, Hvid I. Effects of locally applied vascular endothelial growth factor (VEGF) and VEGF-inhibitor to the rabbit tibia during distraction osteogenesis. J Orthop Res 2003; 21(2): 335-40.
37. Joyce ME, Jingushi S, Bolander ME. Transforming growth factorbeta in the regulation of fracture repair. Orthop Clin North Am 1990; 21(1): 199-209.
38. Hiltunen A, Aro HT, Vuorio E. Regulation of extracellular matrix genes during fracture healing in mice. Clin Orthop Relat Res 1993; 46(297): 23-7.
39. Massague J. The transforming growth factor-beta family. Annu Rev Cell Biol 1990; 6: 597-641.
40. Donovan D, Harmey J, Toomey D, Osborne D, Redmond H, Bouchier-Hayes D. TGF beta-1 regulation of VEGF production by breast cancer cells. Ann Surg Oncol 1997; 4(8): 621-7.
41. Globus RK, Patterson-Buckendahl P, Gospodarowicz D. Regulation of bovine bone cell proliferation by fibroblast growth factor and transforming growth factor beta. Endocrinology 1988; 123(1): 98-105.
42. Koochenkpour S, Merzak A, Pilkington C. Vascular endothelial growth factor production is stimulated by gangliosides and TGF-beta isoforms in human glioma cells in vitro. Cancer Lett 1996; 102: 209-15.
43. Pepper M. Transforming growth factor-beta: Vasculogenesis, angiogenesis, and vessel wall integrity. Cytokine Growth Factor Rev 1997; 8(1): 21-43.
44. Cetrulo CL Jr, Knox KR, Brown DJ, et al. Stem cells and distraction osteogenesis: endothelial progenitor cells home to the ischemic generate in activation and consolidation. Plast Reconstr Surg 2005; 116(4): 1053-64; discussion 65-7.
45. Qi M, Hu J, Zou S, Zhou H, Han L. Mandibular distraction osteogenesis enhanced by bone marrow mesenchymal stem cells in rats. J Craniomaxillofac Surg 2006; 34(5): 283-9.
46. Shao Z, Liu B, Peng Q, et al. Transplantation of osteoblast-like cells to the distracted callus in the rabbit mandible. Plast Reconstr Surg 2007; 119(2): 500-7.
47. Lenton KA, Nacamuli RP, Wan DC, Helms JA, Longaker MT. Cranial suture biology. Curr Top Dev Biol 2005; 66: 287-328.
48. Warren SM, Brunet LJ, Harland RM, Economides AN, Longaker MT. The BMP antagonist noggin regulates cranial suture fusion. Nature 2003; 422(6932): 625-9.
49. Kim HJ, Rice DP, Kettunen PJ, Thesleff I. FGF-, BMP-and Shhmediated signalling pathways in the regulation of cranial suture morphogenesis and calvarial bone development. Development 1998; 125(7): 1241-51.
50. Nacamuli RP, Fong KD, Lenton KA, et al. Expression and possible mechanisms of regulation of BMP3 in rat cranial sutures. Plast Reconstr Surg 2005; 116(5): 1353-62.
51. rd ed. San Diego: Elsevier; 2007; pp. 459-68.
52. rd ed. San Diego: Elsevier 2007; pp. 1253-62.
53. Thomson JA, Itskovitz-Eldor J, Shapiro SS, et al. Embryonic stem cell lines derived from human blastocysts. Science 1998; 282(5391): 1145-7.
54. Weissman IL. Stem cells--scientific, medical, and political issues. N Engl J Med 2002; 346(20): 1576-9.
55. Friedenstein AJ, Piatetzky S II, Petrakova KV. Osteogenesis in transplants of bone marrow cells. J Embryol Exp Morphol 1966; 16(3): 381-90.
56. rd ed. New York: Elsevier 2008; pp. 823-43.
57. Wang HS, Hung SC, Peng ST, et al. Mesenchymal stem cells in the Wharton's jelly of the human umbilical cord. Stem Cells 2004; 22(7): 1330-7.
58. Sarugaser R, Lickorish D, Baksh D, Hosseini MM, Davies JE. Human umbilical cord perivascular (HUCPV) cells: a source of mesenchymal progenitors. Stem Cells 2005; 23(2): 220-9.
59. Lu LL, Liu YJ, Yang SG, et al. Isolation and characterization of human umbilical cord mesenchymal stem cells with hematopoiesissupportive function and other potentials. Haematologica 2006; 91(8): 1017-26.
60. Fu YS, Cheng YC, Lin MY, et al. Conversion of human umbilical cord mesenchymal stem cells in Wharton's jelly to dopaminergic neurons in vitro: Potential therapeutic application for Parkinsonism. Stem Cells 2006; 24(1): 115-24.
61. Karahuseyinoglu S, Cinar O, Kilic E, et al. Biology of stem cells in human umbilical cord stroma: in situ and in vitro surveys. Stem Cells 2007; 25(2): 319-31.
62. Campard D, Lysy PA, Najimi M, Sokal EM. Native umbilical cord matrix stem cells express hepatic markers and differentiate into hepatocyte-like cells. Gastroenterology 2008; 134(3): 833-48.
63. Wang L, Singh M, Bonewald LF, Detamore MS. Signalling strategies for osteogenic differentiation of human umbilical cord mesenchymal stromal cells for 3D bone tissue engineering. J Tissue Eng Regen Med 2009; 3(5): 398-404.
64. Pittenger MF, Mackay AM, Beck SC, et al. Multilineage potential of adult human mesenchymal stem cells. Science 1999; 284(5411): 143-7.
65. Ohgushi H, Goldberg VM, Caplan AI. Repair of bone defects with marrow cells and porous ceramic. Experiments in rats. Acta Orthop Scand 1989; 60(3): 334-9.
66. Bruder SP, Kraus KH, Goldberg VM, Kadiyala S. The effect of implants loaded with autologous mesenchymal stem cells on the healing of canine segmental bone defects. J Bone Joint Surg Am 1998; 80(7): 985-96.
67. Schantz JT, Teoh SH, Lim TC, Endres M, Lam CX, Hutmacher DW. Repair of calvarial defects with customized tissue-engineered bone grafts I. Evaluation of osteogenesis in a three-dimensional culture system. Tissue Eng 2003; 9(Suppl 1): S113-26.
68. Connolly JF, Guse R, Tiedeman J, Dehne R. Autologous marrow injection as a substitute for operative grafting of tibial nonunions. Clin Orthop 1991; (266): 259-70.
69. Connolly JF. Clinical use of marrow osteoprogenitor cells to stimulate osteogenesis. Clin Orthop Relat Res 1998; (355 Suppl): S257-66.
70. Chapman MW, Bucholz R, Cornell C. Treatment of acute fractures with a collagen-calcium phosphate graft material. A randomized clinical trial. J Bone Joint Surg Am 1997; 79(4): 495-502.
71. Garg NK, Gaur S, Sharma S. Percutaneous autogenous bone marrow grafting in 20 cases of ununited fracture. Acta Orthop Scand 1993; 64(6): 671-2.
72. Sim R, Liang TS, Tay BK. Autologous marrow injection in the treatment of delayed and non-union in long bones. Singapore Med J 1993; 34(5): 412-7.
73. Ohgushi H, Caplan AI. Stem cell technology and bioceramics: from cell to gene engineering. J Biomed Mater Res 1999; 48(6): 913-27.
74. Ohgushi H, Kotobuki N, Funaoka H, et al. Tissue engineered ceramic artificial joint--ex vivo osteogenic differentiation of patient mesenchymal cells on total ankle joints for treatment of osteoarthritis. Biomaterials 2005; 26(22): 4654-61.
75. Kawate K, Yajima H, Ohgushi H, et al. Tissue-engineered approach for the treatment of steroid-induced osteonecrosis of the femoral head: transplantation of autologous mesenchymal stem cells cultured with beta-tricalcium phosphate ceramics and free vascularized fibula. Artif Organs 2006; 30(12): 960-2.
76. Im GI, Shin YW, Lee KB. Do adipose tissue-derived mesenchymal stem cells have the same osteogenic and chondrogenic potential as bone marrow-derived cells? Osteoarthritis Cartilage 2005t; 13(10): 845-53.
77. Yoshimura H, Muneta T, Nimura A, Yokoyama A, Koga H, Sekiya I. Comparison of rat mesenchymal stem cells derived from bone marrow, synovium, periosteum, adipose tissue, and muscle. Cell Tissue Res 2007; 327(3): 449-62.
78. Hayashi O, Katsube Y, Hirose M, Ohgushi H, Ito H. Comparison of osteogenic ability of rat mesenchymal stem cells from bone marrow, periosteum, and adipose tissue. Calcif Tissue Int 2008; 82(3): 238-47.
79. Zhou S, Greenberger JS, Epperly MW, et al. Age-related intrinsic changes in human bone-marrow-derived mesenchymal stem cells and their differentiation to osteoblasts. Aging Cell 2008; 7(3): 335-43.
80. Caplan AI. Adult mesenchymal stem cells for tissue engineering versus regenerative medicine. J Cell Physiol 2007; 213(2): 341-7.
81. De Ugarte DA, Morizono K, Elbarbary A, et al. Comparison of multi-lineage cells from human adipose tissue and bone marrow. Cells Tissues Organs 2003; 174(3): 101-9.
82. Zuk PA, Zhu M, Ashjian P, et al. Human adipose tissue is a source of multipotent stem cells. Mol Biol Cell 2002; 13(12): 4279-95.
83. Zuk PA, Zhu M, Mizuno H, et al. Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue Eng 2001; 7(2): 211-28.
84. rd ed. New York: Elsevier 2008; pp. 845-60.
85. Lee JA, Parrett BM, Conejero JA, et al. Biological alchemy: engineering bone and fat from fat-derived stem cells. Ann Plast Surg 2003; 50(6): 610-7.
86. Cowan CM, Shi YY, Aalami OO, et al. Adipose-derived adult stromal cells heal critical-size mouse calvarial defects. Nat Biotechnol 2004; 22(5): 560-7.
87. Yoon E, Dhar S, Chun DE, Gharibjanian NA, Evans GR. In vivo osteogenic potential of human adipose-derived stem cells/poly lactide-co-glycolic acid constructs for bone regeneration in a rat critical-sized calvarial defect model. Tissue Eng 2007; 13(3): 619-27.
88. Lendeckel S, Jodicke A, Christophis P, et al. Autologous stem cells (adipose) and fibrin glue used to treat widespread traumatic calvarial defects: case report. J Craniomaxillofac Surg 2004; 32(6): 370-3.
89. Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006; 126(4): 663-76.
90. Okita K, Nakagawa M, Hyenjong H, Ichisaka T, Yamanaka S. Generation of mouse induced pluripotent stem cells without viral vectors. Science 2008; 322(5903): 949-53.
91. Zhou H, Wu S, Joo JY, et al. Generation of induced pluripotent stem cells using recombinant proteins. Cell Stem Cell 2009; 4(5): 381-4.
92. Verrier S, Boccaccini AR. Bioactive Composite Materials for Bone Tissue Engineering Scaffolds. In: Polak J, Eds. Advances in Tissue Engineering. London: Imperial College Press 2008; pp. 279-311.
93. Wiesmann HP, Lammers L. Scaffold Structure and Fabriction. In: Meyer U, Handschel J, Meyer T, Wiesmann HP, Eds. Fundamentals of Tissue Engineering and Regenerative Medicine, Heidelberg: Springer 2009; pp. 539-49.
94. Leonor IB, Ito A, Onuma K, Kanzaki N, Reis RL. In vitro bioactivity of starch thermoplastic/hydroxyapatite composite biomaterials: an in situ study using atomic force microscopy. Biomaterials 2003; 24(4): 579-85.
95. Cortizo MS, Molinuevo MS, Cortizo AM. Biocompatibility and biodegradation of polyester and polyfumarate based-scaffolds for bone tissue engineering. J Tissue Eng Regen Med 2008; 2(1): 33-42.
96. Hou Q, Chau DY, Pratoomsoot C, et al. In situ gelling hydrogels incorporating microparticles as drug delivery carriers for regenerative medicine. J Pharm Sci 2008; 97(9): 3972-80.
97. Qiao M, Chen D, Ma X, Liu Y. Injectable biodegradable temperature-responsive PLGA-PEG-PLGA copolymers: synthesis and effect of copolymer composition on the drug release from the co-polymer-based hydrogels. Int J Pharm 2005; 294(1-2): 103-12.
98. Stile RA, Healy KE. Thermo-responsive peptide-modified hydrogels for tissue regeneration. Biomacromolecules 2001; 2(1): 185-94.
99. Stile RA, Healy KE. Poly(N-isopropylacrylamide)-based semiinterpenetrating polymer networks for tissue engineering applications. 1. Effects of linear poly(acrylic acid) chains on phase behavior. Biomacromolecules 2002; 3(3): 591-600.
100. rd ed. Elsevier 2007; pp. 341-58.
101. Baksh D, Song L, Tuan RS. Adult mesenchymal stem cells: characterization, differentiation, and application in cell and gene therapy. J Cell Mol Med 2004; 8(3): 301-16.
102. Gregory CA, Prockop DJ, Spees JL. Non-hematopoietic bone mar-row stem cells: molecular control of expansion and differentiation. Exp Cell Res 2005; 306(2): 330-5.
103. Tuan RS, Boland G, Tuli R. Adult mesenchymal stem cells and cell-based tissue engineering. Arthritis Res Ther 2003; 5(1): 32-45.